S&C Advises PharmaSGP in Germany’s first IPO on the regulated market in 2020June 22, 2020
With clients turning to S&C in the most challenging of times, a Frankfurt-led S&C team advised PharmaSGP on the first Prime Standard IPO in Germany this year. PharmaSGP priced its IPO on June 18 at an offering size of €127 million (including over-allotments), corresponding to a market capitialization of €378 million. Shares began trading on the regulated market of the Frankfurt Stock Exchange on June 19.
Pharma SGP is a pharmaceutical company headquartered near Munich with a broad portfolio of leading non-chemical, over-the-counter drugs and other healthcare products.
The S&C team in Frankfurt advising PharmaSGP was led by Carsten Berrar, Krystian Czerniecki and Felix Ganzer.